Beta Drugs Ltd
company logo

Beta Drugs Ltd

Beta Drugs Ltd Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Invest in Beta Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Beta Drugs Ltd Performance

-

-

-

-


-

-

-

-

-

Beta Drugs Ltd Fundamentals

Read More

2,004.38Cr

55.01

12.76

0.12

37.90

0%

163.43

Beta Drugs Ltd Financials

Beta Drugs Ltd Financialsright-arrow

Beta Drugs Ltd Shareholding Pattern

Beta Drugs Ltd Delivery and Volume

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 20

Varun Batra

2005

BETA

NameDesignation
Balwant Singh.Whole-time Director
Varun BatraJoint Managing Director
Rahul BatraChairperson & M D
Manmohan KhannaIndependent Director
Rohit PartiIndependent Director
Rajni BrarCompany Sec. & Compli. Officer
Seema ChopraWhole-time Director
Ashutosh ShuklaWhole-time Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Beta Drugs Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Beta Drugs Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Beta Drugs Ltd's share price is ₹2084.9 as of 2024-11-23.
Beta Drugs Ltd's P/E ratio is 55.01 times as of 2024-11-23.
Beta Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 12.76, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Beta Drugs Ltd's market capitalization is ₹2004.38 Cr as on 2024-11-23.
The current financial records of Beta Drugs Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Beta Drugs Ltd's most recent financial filings, the company has a total asset value of ₹114.49, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Beta Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Beta Drugs Ltd's 52-week high and low as of 2024-11-23 are ₹2108.9 and ₹1983, respectively.